T67788 |
BAY-43-9695
|
233255-39-5
|
98%
|
|
BAY-43-9695 is a non-nucleoside compound with anti-human cytomegalovirus (HCMV) activity. It is the major metabolite of BAY-38-4766.
|
T27586 |
IDX184
|
1036915-08-8
|
98%
|
|
IDX184 is a potent, orally active, targeted HCV polymerase inhibitor and nucleoside polymerase.IDX184 effectively inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 ...
|
T26815 |
BILB-1941
|
494856-61-0
|
98%
|
|
BILB-1941 is an inhibitor of HCV NS5B polymerase and can be used in studies about HCV infection.
|
T28830 |
Sovaprevir
|
1001667-23-7
|
98%
|
|
Sovaprevir is a non-structural 3 (NS3) protease inhibitor with antiviral activity for the treatment of HCV infection.
|
T27696 |
JTK-109
|
480462-62-2
|
98%
|
|
JTK-109 is an inhibitor of hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor and inhibits G1b and G3a subgenomic replicons and recombinant enzymes.
|
T67787 |
Adafosbuvir PM
|
1613589-04-0
|
98%
|
|
Adafosbuvir PM is a small molecule NS5B inhibitor that can be used to study chronic hepatitis C.
|
T26863 |
BMS-929075
|
1217338-97-0
|
98%
|
|
BMS-929075 is an orally active HCV NS5B replicase (HCV NS5B replicase) palm site variant inhibitor with potency, high oral bioavailability and pharmacokinetic pa...
|
T68015 |
Ruzasvir
|
1613081-64-3
|
98%
|
|
Ruzasvir is a novel and potent pan-genotypic inhibitor of hepatitis C virus NS5A with antiviral activity.
|
T24480 |
MK-8325
|
1334314-19-0
|
98%
|
|
MK-8325 is a potent and orally available HCV NS5A inhibitor with replicative activity against a wide range of genotypes.MK-8325 has demonstrated bioavailability ...
|
T28762 |
Setrobuvir
|
1071517-39-9
|
98%
|
|
Setrobuvir is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s betw...
|
TN1033 |
Sennidin A
|
641-12-3
|
98%
|
|
Sennidin A, has two hydroxyanthraquinone-like moieties, exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.
|
TN1138 |
γ-Fagarine
|
524-15-2
|
98%
|
|
gamma-Fagarine possesses moderate levels of anti-HCV activities with IC50 values being 20.4 ± 0.4 ug/ml, respectively. It has sister chromatid exchanges (SCEs)-i...
|
TN1034 |
Sennidin B
|
517-44-2
|
98%
|
|
Sennidin B stimulates glucose incorporation in rat adipocytes.
|
T5539 |
GS-443902
|
1355149-45-9
|
98%
|
|
GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at lea...
|
TN3809 |
Dehydrojuncusol
|
117824-04-1
|
98%
|
|
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is acti...
|
T12966 |
Sofosbuvir impurity K
|
1496552-51-2
|
98%
|
|
Sofosbuvir impurity K is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.
|
T12969 |
Sofosbuvir impurity N
|
1394157-34-6
|
98%
|
|
Sofosbuvir impurity N is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.
|
T12033 |
Micrococcin P1
|
67401-56-3
|
98%
|
|
Micrococcin P1 is a macrocyclic peptide antibiotic and is a potent hepatitis C virus (HCV) inhibitor(EC50 range of 0.1-0.5 μM)
|
T12965 |
Sofosbuvir impurity J
|
1334513-10-8
|
98%
|
|
Sofosbuvir impurity J is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.
|
T12963 |
Sofosbuvir impurity H
|
T12963
|
98%
|
|
Sofosbuvir impurity H, an diastereoisomer of Sofosbuvir, is the impurity of Sofosbuvir. Sofosbuvir (PSI-7977) is a diastereoisomer of Sofosbuvir.Sofosbuvir is an...
|